Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|February 27, 2026
Ruxolitinib treatment for myelofibrosis with anemia: a retrospective assessment of real-world patient characteristics, treatment patterns, and survivalAndrew T Kuykendall, Francesca Palandri, Mirko Fillbrunn, et al.
Future Oncology (London, England)|July 29, 2024
Transfusion-related cost offsets and time burden in patients with myelofibrosis on momelotinib vs. danazol from MOMENTUMLucia Masarova, Srdan Verstovsek, Tom Liu, et al.
Future Oncology (London, England)|June 6, 2025
Indirect treatment comparison of momelotinib vs fedratinib safety in patients with myelofibrosisLucia Masarova, Srdan Verstovsek, Francesca Palandri, et al.
Plos One|June 20, 2020
Prognostic factors for changes in the timed 4-stair climb in patients with Duchenne muscular dystrophy, and implications for measuring drug efficacy: A multi-institutional collaborationNathalie Goemans, Brenda Wong, Marleen Van den Hauwe, et al.
Plos One|June 3, 2024
Functional trajectories before and after loss of ambulation in Duchenne muscular dystrophy and implications for clinical trialsCraig M McDonald, James Signorovitch, Eugenio Mercuri, et al.
European Journal of Epidemiology|April 26, 2022
APOE ε4 and late-life cognition: mediation by structural brain imaging markersYuan Ma, Gautam Sajeev, Tyler J VanderWeele, et al.
Muscle & Nerve|October 11, 2019
Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta-analysis of disease progression rates in recent multicenter clinical trialsCraig M McDonald, Gautam Sajeev, Zhiwen Yao, et al.
Neurology|February 27, 2023
Longitudinal Assessment of Creatine Kinase, Creatine/Creatinine<sub>ratio</sub>, and Myostatin as Monitoring Biomarkers in Becker Muscular DystrophyNienke M van de Velde, Zaïda Koeks, Mirko Signorelli, et al.
Blood Neoplasia|January 19, 2026
Outcomes of myeloablative allogeneic hematopoietic cell transplantation with omidubicel vs alternative donor sourcesChenyu Lin, Smitha Sivaraman, Gautam Sajeev, et al.
Neurology|May 26, 2026
A Validated Prognostic Score for Time to Loss of Ambulation in Patients With Duchenne Muscular DystrophyCraig M McDonald, James Signorovitch, Nathalie Marie Goemans, et al.
Pageof 4